C4 Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	74.6	55.5	29.75	76.12	181.73
Short-Term Investments	173.93	189.41	246.4	233.16	189.96
Cash & Short-Term Investments	248.54	244.9	276.15	309.28	371.69
Cash Growth	1.48%	-11.32%	-10.71%	-16.79%	310.48%
Accounts Receivable	2.4	3.1	1.47	5.72	4.48
Other Current Assets	7.17	9.76	9.93	10.69	4.84
Total Current Assets	258.11	257.77	287.56	325.69	381.01
Net Property, Plant & Equipment	45.28	63.38	77.52	35.05	16.55
Long-Term Investments	48.56	22.36	60.96	142.2	-
Other Long-Term Assets	7.13	6.1	4.81	3.82	2.58
Total Assets	359.08	349.6	430.84	506.77	400.14
Accounts Payable	0.86	1.33	1.17	4.51	5.68
Accrued Expenses	13.31	19.36	19.77	13.61	9.52
Current Portion of Long-Term Debt	-	-	2.29	-	-
Current Portion of Leases	6.37	5.77	4.7	1.33	1.04
Unearned Revenue	12.49	18.71	16.62	31.8	27.6
Total Current Liabilities	33.03	45.18	44.55	51.25	43.85
Long-Term Debt	-	-	9.2	10.77	10.05
Long-Term Leases	53.62	59.98	70.97	30.78	11.83
Other Long-Term Liabilities	15.84	28.46	16.9	24.37	53.62
Total Long-Term Liabilities	69.46	88.44	97.06	65.91	75.5
Total Liabilities	102.49	133.62	141.61	117.16	119.35
Common Stock	0.01	0.01	0.01	0.01	0
Additional Paid-in Capital	995.22	849.63	689.26	658.09	464.6
Accumulated Other Comprehensive Income	0.05	0.05	-4.14	-0.78	0.01
Retained Earnings	-738.69	-633.7	-395.89	-267.72	-183.82
Total Common Shareholders' Equity	256.59	215.99	289.23	389.61	280.79
Shareholders' Equity	256.59	215.99	289.23	389.61	280.79
Total Liabilities & Equity	359.08	349.6	430.84	506.77	400.14
Total Debt	59.98	65.76	87.15	42.88	22.92
Net Cash (Debt)	188.56	179.15	189	266.4	348.77
Net Cash Growth	5.25%	-5.21%	-29.05%	-23.62%	354.13%
Net Cash Per Share	2.27	2.58	3.87	5.79	30.67
Book Value	256.59	215.99	289.23	389.61	280.79
Book Value Per Share	3.10	3.11	5.92	8.46	24.70
Tangible Book Value	256.59	215.99	289.23	389.61	280.79
Tangible Book Value Per Share	3.10	3.11	5.92	8.46	24.70

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q